The United States is facing a dwindling stockpile of missiles, raising concerns about its military readiness and ability to respond to emerging threats. The depletion of missile stockpiles is attributed to various factors, including increased demand, production delays, and supply chain disruptions. Meanwhile, the Food and Drug Administration (FDA) is considering the approval of flu shots that utilize mRNA technology. This innovative approach has shown promise in providing effective protection against the flu, and its approval could mark a significant breakthrough in vaccine development. The FDA’s decision will be based on the results of clinical trials, which have demonstrated the safety and efficacy of the mRNA-based flu shots. As the US military seeks to replenish its missile stockpiles, the approval of mRNA-based flu shots could have a positive impact on public health, particularly in the context of the ongoing pandemic. The intersection of these two issues highlights the complex and interconnected nature of national security and public health.
On top of everything as it happens